Grow out loud with the #1 prescribed pill* for severe alopecia areata

LITFULO is an FDA-approved, once-daily pill for adults, teens, and tweens ages 12+ with severe alopecia areata.

In just under 6 months, 23% of people taking LITFULO in the clinical study saw 80% or more scalp hair coverage (vs 1.6% on placebo) and 13.4% of people taking LITFULO saw 90% or more scalp hair coverage (vs 1.5% on placebo). Individual results may vary. See more results from the LITFULO clinical study.

*Based on new prescriptions since January 2025.

style
Section-banner-homepage, padding-bottom-medium

LITFULO may cause serious side effects, including:

serious infections; increased risk of death; cancer and immune system problems; increased risk of major cardiovascular events; blood clots; allergic reactions; low blood sugar in people with diabetes; and changes in certain laboratory test results. Always talk to your doctor about side effects and learn more about these serious risks and additional safety information for LITFULO.

See what's possible in just under 6 months with LITFULO

Check out clinical study photos of scalp hair regrowth on people with severe alopecia areata who took LITFULO. Individual results may vary. Not everyone will respond to LITFULO.

See results

Clinical study photos showing adult and 12+ patients with severe alopecia areata before and after taking LITFULO (ritlecitinib) Clinical study photos showing adult and 12+ patients with severe alopecia areata before and after taking LITFULO (ritlecitinib)

Pay as little as $0 for LITFULO†

Find out if you’re eligible to save on treatment and learn about other financial assistance options.

Explore your options

Real stories

Watch patients and experts share their experiences with severe alopecia areata and LITFULO.

Watch now

Talk to a dermatologist about LITFULO

Prepare for your dermatologist appointment with a doctor discussion guide.

Create your guide

/global/fragments/foot-note-home
style
No-padding-bottom